Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Ok here is a PR that is "PAR" for PTSC.. PDGS will not hit the 3-6 million ..

Why do they publish this pr today while at the same time the '584 gets revalidated???

They never published anything before their numbers, no matter if numbers were higher or lower than expected.

Sorry to repeat myself but today's pr looks as if they try to avoid any positive shareprice appreciation which could be caused by the '584 development.

Any other thoughts?

Share
New Message
Please login to post a reply